# Carlisle Companies Inc: Form 10-Q for the period ended Mar 31, 2021

- Company: [Carlisle Companies Inc](/companies/csl.md) (CIK 790051)
- Form: 10-Q
- Filed: 2021-04-27
- Accepted by EDGAR: Apr 27, 2021, 14:57 ET
- Period: 2021-03-31
- Accession: 0000790051-21-000116
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/790051/000079005121000116/csl-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/790051/000079005121000116/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $1.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-01-01 to 2021-03-31 | $767.3m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2021-01-01 to 2021-03-31 | $12.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $159.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $89.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $19.2m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $14.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $52.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 53,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | $67.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $20.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2021-01-01 to 2021-03-31 | $28.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2021-01-01 to 2021-03-31 | $150.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2021-03-31 | $2.14bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $5.75bn | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $660.1m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2021-03-31 | $2.08bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-03-31 | $1.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-03-31 | $2.41bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,432 characters.

Carlisle Companies Incorporated (“Carlisle”, the “Company”, “we”, “us” or “our”) is a diversified, global portfolio of niche brands and businesses that manufactures highly engineered products and solutions for its customers. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior shareholder and stakeholder returns by combining an entrepreneurial management style under a center-led approach, and balanced capital deployment, all with a culture of responsible stewardship and continuous improvement as embodied in the Carlisle Operating System ("COS"). Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report on Form 10-Q.

### Executive Overview

Reflecting on the past twelve months of uncertainty, we take great pride in how the Carlisle team handled the immediate threats born out of the COVID-19 pandemic, monitoring that strict health and safety protocols were in place and followed, which has led to a low infection rate at Carlisle facilities across the globe. This reaction enabled an early, proactive focus on positioning our business for an economic rebound, with Vision 2025 providing the clear direction and consistency of mission to guide our efforts. One year removed from the pandemic's initial impact, we believe we are a stronger company and well positioned to meet our center-led Vision 2025 objectives, supported by confidence in the fundamentals of our businesses and our commitment to our customers through the Carlisle Experience.

As a result of the strength in our Carlisle Construction Materials ("CCM"), Carlisle Fluid Technologies ("CFT"), and Carlisle Brake & Friction ("CBF") businesses, our consolidated revenue was relatively flat year-over-year despite a tough comparison and well publicized impact of the COVID-19 pandemic on the aerospace industry that continues to weigh on Carlisle Interconnect Technologies ("CIT") results. The first quarter of 2021 demonstrated yet again Carlisle's ability to navigate varying economic cycles while delivering strong financial performance. We continued to execute on our long-term strategies, including: maintaining the highest standards in providing the Carlisle Experience to our customers, investing in high-return projects to drive organic growth across our core platforms, working an active pipeline of acquisition targets, returning excess capital to shareholders through share repurchases and dividends, continuing on our environmental, social and governance ("ESG") journey, and demonstrating the exceptional and sustainable earnings power of the Carlisle business model.

We remain balanced in our capital deployment approach by investing in our businesses, repurchasing $150.0 million of shares and maintaining our cash dividend payments of $28.4 million during the quarter. As of the end of the first quarter, we have a strong cash position of $767.2 million with $1.0 billion undrawn on our revolving credit facility (the "Facility").

Vision 2025 continues to provide Carlisle clear direction. We have stayed the course on our strategy throughout the past year and have regained positive momentum across all segments. Additionally, we continue to pursue acquisition opportunities, and we expect to be active in augmenting our core businesses with synergistic acquisitions. We are well positioned to accelerate through the recovery.

#### Summary of Financial Results

*(in millions, except per share amounts)*

|  | Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Revenues | $1,029.0 | $1,030.2 |
| Operating income | $89.5 | $102.7 |
| Operating margin percentage | 8.7% | 10.0% |
| Net income | $52.2 | $61.8 |
| Diluted earnings per share attributable to common shares | $0.97 | $1.09 |
| Non-comparable items(1) | $8.3 | $16.0 |

(1) Non-comparable items include items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

Revenues were relatively flat in the first quarter of 2021 primarily reflecting lower volumes in our CIT segment, which has continued to be impacted by the prolonged aerospace decline, offset by higher volumes in our CCM, CBF and CFT segments and favorable foreign currency impacts.

The decrease in operating income in the first quarter of 2021 primarily reflected raw material and wage inflation across all segments, and unfavorable mix at CIT. The decrease in operating income was partially offset by savings from COS and lower travel costs.

Diluted earnings per share decreased primarily due to the above operating income performance ($0.18 per share in the first quarter of 2021) and a higher effective tax rate ($0.03 per share in the first quarter of 2021). The decrease was partially offset by reduced average shares outstanding ($0.05 per share in the first quarter of 2021) resulting from purchases under our share repurchase program.

We generated $67.6 million in operating cash flow in the first three months of 2021, and utilized cash on hand and cash provided by operations to return capital to shareholders through dividends and share repurchases, and to fund capital expenditures.

### Consolidated Results of Operations

### Revenues

*(in millions)*

|  | 2021 | 2020 | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Three months ended March 31 | $1,029.0 | $1,030.2 | $(1.2) | (0.1)% | 0.4% | (1.4)% | 0.9% |

Revenues were relatively flat in the first quarter of 2021 primarily reflecting lower CIT volumes as a result of the prolonged aerospace decline, offset by higher sales volumes in our CCM, CBF and CFT segments across most markets in which they operate and favorable foreign currency impacts.

### Gross Margin

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Gross margin | $261.7 | $278.4 | $(16.7) | (6.0)% |
| Gross margin percentage | 25.4% | 27.0% |  |  |
| Depreciation and amortization | $28.4 | $31.5 |  |  |

Gross margin percentage (gross margin expressed as a percentage of revenues) declined in the first quarter of 2021, driven by raw material and wage inflation, and unfavorable mix at our CIT segment, partially offset by savings from COS. Also included in cost of goods sold were exit and disposal costs totaling $0.8 million for the first quarter of 2021, primarily at CIT, attributable to our restructuring initiatives, compared with $3.0 million for the first quarter of 2020. Refer to Note 7 for further information on exit and disposal activities.

### Selling and Administrative Expenses

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Selling and administrative expenses | $159.8 | $161.9 | $(2.1) | (1.3)% |
| As a percentage of revenues | 15.5% | 15.7% |  |  |
| Depreciation and amortization | $25.3 | $24.7 |  |  |

The decrease in selling and administrative expenses in the first quarter of 2021 primarily reflected lower travel costs, partially offset by higher medical costs and wage inflation. Also included in selling and administrative expenses were exit and disposal costs totaling $0.6 million for the first quarter of 2021, primarily at CIT, attributable to our restructuring initiatives, compared with $1.6 million for the first quarter of 2020. Refer to Note 7 for further information on exit and disposal activities.

### Research and Development Expenses

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development expenses | $12.6 | $14.4 | $(1.8) | (12.5)% |
| As a percentage of revenues | 1.2% | 1.4% |  |  |
| Depreciation and amortization | $0.6 | $0.6 |  |  |

Research and development expenses were lower in the first quarter of 2021, compared with the first quarter of 2020, primarily reflecting lower new product development expenses at our CIT and CCM segments.

### Other Operating Income, net

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Other operating income, net | $(0.2) | $(0.6) | $0.4 | (66.7)% |

Other operating income, net in the first quarter of 2021 primarily reflected $0.9 million of rebates and $0.3 million of royalty income, partially offset by a litigation settlement of $0.6 million and an insurance settlement of $0.3 million at CBF.

Other operating income, net in the first quarter of 2020 primarily reflected $0.5 million of rebates and $0.3 million of royalty income, partially offset by $0.7 million of losses on sale of assets, primarily at CCM.

### Operating Income

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Operating income | $89.5 | $102.7 | $(13.2) | (12.9)% |
| Operating margin percentage | 8.7% | 10.0% |  |  |

Refer to *Segment Results of Operations* within this MD&A for further information related to segment operating income results.

### Interest Expense, net

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Interest expense, net | $19.2 | $18.9 | $0.3 | 1.6% |

Interest expense, net of capitalized interest, during the first quarter of 2021 primarily reflected higher long-term debt balances associated with our public offering of $750.0 million of 2.75% unsecured senior notes completed in February 2020. Refer to Note 11 for further information on our long-term debt.

### Loss on Extinguishment of Debt

Loss on extinguishment of debt of $8.8 million in the first quarter of 2020 related to the early redemption in full of our $250.0 million aggregate principal amount of our outstanding 5.125% notes due December 15, 2020 (the “2020 Notes”). The 2020 Notes were redeemed on March 29, 2020 at the redemption price of $262.1 million. The redemption price included a premium of $8.4 million, along with $0.4 million of deferred issuance costs.

### Interest Income

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Interest income | $(0.5) | $(0.7) | $0.2 | (28.6)% |

Interest income decreased during the first quarter of 2021 primarily reflecting lower cash balances and lower yields.

### Other Non-operating Expense (Income), net

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | --- |
| Other non-operating expense (income), net | $3.9 | $(0.5) | $4.4 | NM |

Other non-operating expense (income), net in the first quarter of 2021 primarily reflected the release of a portion of the indemnification asset related to the Petersen Aluminum Corporation ("Petersen") acquisition resulting from escrow expirations and changes in foreign currencies against the U.S. Dollar.

Other non-operating expense (income), net, in the first quarter of 2020 primarily reflected foreign exchange gains from the strengthening of the U.S. Dollar, partially offset by release of a portion of the indemnification asset related to the Petersen acquisition resulting from escrow expirations.

### Income Taxes

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Provision for income taxes | $14.7 | $14.4 | $0.3 | 2.1% |
| Effective tax rate | 22.0% | 18.9% |  |  |

The effective income tax rate on continuing operations for the first quarter of 2021 was 22.0%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 24.5% and a tax impact of $1.7 million related to discrete activity. The first-quarter net discrete tax benefit relates primarily to a reduction of prior year tax liabilities and excess tax benefits related to stock compensation.

The effective income tax rate on continuing operations for the first three months of 2020 was 18.9%.

### Segment Results of Operations

### Carlisle Construction Materials ("CCM")

CCM continues to benefit from the strong re-roofing cycle in the United States. In the first quarter, CCM delivered mid-single digit growth, demonstrating the resilience of this demand. Energy-efficient building envelope products and solutions for nonresidential buildings are non-discretionary and can only be deferred for so long. This factor was highlighted by the inclement weather experienced in North America in February only temporarily impacting sales at CCM, with March volumes more than offsetting the delay.

On April 20, Carlisle announced plans to build an innovative, state-of-the-art polyiso insulation manufacturing facility in Sikeston, Missouri. Consistent with Carlisle’s Vision 2025 strategy to invest in high-returning businesses to drive organic growth, the plant will support organic growth initiatives and create new jobs for the city of Sikeston and surrounding communities. The building will be constructed in accordance with the latest advances in LEED building and ESG principles. Additionally, we expect that this central location will reduce our supply chain carbon footprint and improve material lead times for customers in this region where the use of insulation in the building envelope is steadily increasing. At the new facility, CCM will manufacture energy-efficient polyiso insulation, which not only lowers energy costs for building owners and operators, but also helps reduce a building's greenhouse gas emissions.

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $719.3 | $676.4 | $42.9 | 6.3% | —% | 5.7% | 0.6% |
| Operating income | $121.3 | $107.7 | $13.6 | 12.6% |  |  |  |
| Operating margin percentage | 16.9% | 15.9% |  |  |  |  |  |
| Depreciation and amortization | $23.4 | $24.8 |  |  |  |  |  |
| Non-comparable items(1) | $2.3 | $0.6 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CCM’s revenue increased in the first quarter of 2021 primarily reflecting higher volumes from strength in U.S. commercial roofing demand.

CCM’s operating margin percentage increase in the first quarter of 2021 primarily reflected higher volumes, lower travel and other administrative costs, and savings from COS, partially offset by raw material and wage inflation.

### Carlisle Interconnect Technologies ("CIT")

CIT's results were in line with subdued expectations given the ongoing disruption in the commercial aerospace market. Given improving leading indicators, which include expanding vaccine rollout, increasing number of domestic travelers, growing aircraft manufacturers' backlogs and improvements in CIT's order book, we believe CIT is positioned for sequential improvement going forward. Taken together with the improving backlog in our medical technologies business, we are optimistic CIT will return to growth in the second half of 2021.

In 2020, as a result of the market declines caused by the effects of the COVID-19 pandemic, we announced the closure of our manufacturing operations in Kent, Washington, and the relocation of selected operations to our existing facilities primarily in North America. This project is estimated to take 12 to 18 months to complete. Total project costs are expected to approximate $18.7 million, with approximately $10.1 million remaining to be incurred.

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $155.8 | $224.5 | $(68.7) | (30.6)% | 0.8% | (31.5)% | 0.1% |
| Operating (loss) income | $(10.7) | $16.4 | $(27.1) | (165.2)% |  |  |  |
| Operating margin percentage | (6.9)% | 7.3% |  |  |  |  |  |
| Depreciation and amortization | $18.9 | $19.1 |  |  |  |  |  |
| Non-comparable items(1) | $2.8 | $3.4 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CIT's revenue decline in the first quarter of 2021 primarily reflected lower volumes, led by the downturn in the commercial aerospace market as a result of slow recovery in build rates on narrow and wide body aircraft by original equipment manufacturers ("OEMs") given declines in airline travel.

CIT’s operating margin percentage decrease in the first quarter of 2021 was driven by lower volumes, unfavorable mix, and raw material and wage inflation, partially offset by savings from COS and lower travel and other administrative costs.

### Carlisle Fluid Technologies ("CFT")

CFT delivered improved revenue and operating income performance in the quarter driven by a commitment to new product introductions, price discipline and integrating our newer platforms. With end markets strengthening, especially general industrial, the team continues to execute on Vision 2025 initiatives and focus on enhancing our customers' experience.

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $65.8 | $58.3 | $7.5 | 12.9% | 4.1% | 5.3% | 3.5% |
| Operating income | $4.3 | $2.8 | $1.5 | 53.6% |  |  |  |
| Operating margin percentage | 6.5% | 4.8% |  |  |  |  |  |
| Depreciation and amortization | $5.6 | $6.2 |  |  |  |  |  |
| Non-comparable items(1) | $0.7 | $0.2 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CFT's revenue increased in the first quarter of 2021 reflecting increased volumes, particularly in the general industrial end market, contributions from acquisitions and favorable foreign currency impacts.

CFT’s operating margin percentage performance improved in the first quarter of 2021 reflecting lower travel and other administrative costs, higher volumes and savings from COS, partially offset by wage and raw material inflation.

### Carlisle Brake & Friction ("CBF")

At CBF, the actions taken to improve the business over the past few years are yielding expected results. In addition to these actions, demand for off-highway vehicles and equipment, especially in agricultural and construction markets, is helping to drive CBF's recovery. CBF has leveraged this volume growth to deliver positive and improving earnings. As a result, we are optimistic that 2021 will prove to be a point of inflection for CBF as it emerges from a multi-year down cycle. Additionally, we view any future infrastructure legislation in the U.S. as another positive driver for CBF.

*(in millions)*

| 2021 | Three Months Ended March 31, 2020 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $88.1 | $71.0 | $17.1 | 24.1% | —% | 20.4% | 3.7% |
| Operating income (loss) | $6.1 | $(3.8) | $9.9 | 260.5% |  |  |  |
| Operating margin percentage | 6.9% | (5.4)% |  |  |  |  |  |
| Depreciation and amortization | $5.0 | $5.9 |  |  |  |  |  |
| Non-comparable items(1) | $0.9 | $2.8 |  |  |  |  |  |

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CBF's revenue increased in the first quarter of 2021 reflecting strong volumes, particularly in the heavy equipment end market and favorable foreign exchange impacts.

CBF's operating margin percentage increase in the first quarter of 2021 was driven by higher volumes, lower restructuring charges and savings from COS, partially offset by unfavorable mix and wage inflation.

### Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:

*(in millions)*

|  | March 31, 2021 | December 31, 2020 |
| --- | ---: | ---: |
| Europe | $116.9 | $114.8 |
| North America (excluding U.S.) | 42.3 | 50.8 |
| China | 21.3 | 19.3 |
| Asia Pacific (excluding China) | 53.1 | 30.1 |
| International cash and cash equivalents | 233.6 | 215.0 |
| U.S. cash and cash equivalents | 533.6 | 687.2 |
| Total cash and cash equivalents | $767.2 | $902.2 |

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under our Facility. In the near term, cash on hand is our primary source of liquidity. The decrease in cash and cash equivalents compared to December 31, 2020, primarily related to share repurchases, payment of dividends to shareholders and capital expenditures.

In certain countries, primarily China, our cash is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash, both temporarily and permanently outside of that jurisdiction. In addition, upon permanent transfer of cash outside of certain jurisdictions, primarily in China, we may be subject to withholding taxes, and as such we have accrued $3.1 million in anticipation of those taxes as of March 31, 2021.

We believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on capital expenditures, dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, as well as available liquidity under the Facility, to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We may access the capital markets to repay the outstanding balance. Refer to *Debt Instruments* below.

### Sources and Uses of Cash and Cash Equivalents

*(in millions)*

|  | Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $67.6 | $53.2 |
| Net cash used in investing activities | (28.4) | (24.3) |
| Net cash (used in) provided by financing activities | (172.8) | 813.0 |
| Effect of foreign currency exchange rate changes on cash | (1.4) | (5.4) |
| Change in cash and cash equivalents | $(135.0) | $836.5 |

#### Operating Activities

We generated operating cash flows of $67.6 million for the first three months of 2021 (including working capital uses of $54.0 million), compared with $53.2 million for the first three months of 2020 (including working capital uses of $96.0 million). Higher operating cash flows in the first three months of 2021 primarily reflected an improvement in net working capital due to supply chain management, partially offset by an increase in receivables from higher sales towards the end of the quarter.

#### Investing Activities

Cash used in investing activities of $28.4 million for the first three months of 2021 primarily reflected capital expenditures of $20.0 million and investment in securities of $10.2 million. Cash used in investing activities of $24.3 million for the first three months of 2020 primarily reflected capital expenditures of $22.8 million.

#### Financing Activities

Cash used in financing activities of $172.8 million in the first three months of 2021 primarily reflected share repurchases of $150.0 million and cash dividend payments of $28.4 million, reflecting the increased quarterly dividend of $0.525 per share. Cash provided by financing activities of $813.0 million during the first three months of 2020 primarily reflected net proceeds from our February 2020 offering of $750 million of senior notes and draws under the Facility, partially offset by the early redemption of our $250 million of senior notes due December 15, 2020 and financing costs associated with our February notes offering. Additionally during the first three months of 2020 we used cash of $120.6 million for share repurchases and $28.3 million for dividend payments.

### Debt Instruments

#### Revolving Credit Facility (the "Facility")

During the three months ended March 31, 2021, we had no borrowings or repayments under the Facility. As of March 31, 2021, the Facility had no outstanding balance and $1.0 billion of availability. During the quarter ended March 31, 2020, borrowings under the Facility totaled $500.0 million, which were subsequently repaid during the second quarter of 2020.

#### Debt Covenants

We are required to meet various covenants and limitations under our senior notes and Facility, including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of March 31, 2021 and December 31, 2020.

Refer to Note 11 for further information on our debt instruments.

### Non-GAAP Financial Measures

### EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin

Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before income, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about the Company's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies. This information differs from net income and operating income determined in accordance with U.S. GAAP and should not be considered in isolation or as a substitute for measures of performance determined in accordance with U.S. GAAP. The Company's and its segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.

*(in millions)*

|  | Three Months Ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Net income (GAAP) | $52.2 | $61.8 |
| Provision for income taxes | 14.7 | 14.4 |
| Interest expense, net | 19.2 | 18.9 |
| Interest income | (0.5) | (0.7) |
| EBIT | 85.6 | 94.4 |
| Exit and disposal, and facility rationalization costs | 3.1 | 6.3 |
| Inventory step-up amortization and acquisition costs | 0.9 | 0.7 |
| Impairment charges | — | — |
| Losses from acquisitions and disposals | 3.4 | 0.2 |
| Losses from insurance | 0.3 | — |
| Losses from litigation | 0.6 | — |
| Losses on extinguishment of debt | — | 8.8 |
| Total non-comparable items | 8.3 | 16.0 |
| Adjusted EBIT | 93.9 | 110.4 |
| Depreciation | 23.7 | 24.6 |
| Amortization | 30.6 | 32.2 |
| Adjusted EBITDA | $148.2 | $167.2 |
| Divided by: |  |  |
| Total revenues | $1,029.0 | $1,030.2 |
| Adjusted EBITDA margin | 14.4% | 16.2% |

24

*(in millions)*

|  | Three Months Ended March 31, 2021 CCM | CIT | CFT | CBF | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $121.3 | $(10.7) | $4.3 | $6.1 | $(31.5) |
| Non-operating expense(1) | 2.2 | — | 0.4 | 0.3 | 1.0 |
| EBIT | 119.1 | (10.7) | 3.9 | 5.8 | (32.5) |
| Exit and disposal, and facility rationalization costs | — | 2.5 | 0.6 | — | — |
| Inventory step-up amortization and acquisition costs | — | — | 0.1 | — | 0.8 |
| Impairment charges | — | — | — | — | — |
| Losses from acquisitions and disposals | 2.3 | 0.3 | — | — | 0.8 |
| Losses from insurance | — | — | — | 0.3 | — |
| Losses from litigation | — | — | — | 0.6 | — |
| Losses on extinguishment of debt | — | — | — | — | — |
| Total non-comparable items | 2.3 | 2.8 | 0.7 | 0.9 | 1.6 |
| Adjusted EBIT | 121.4 | (7.9) | 4.6 | 6.7 | (30.9) |
| Depreciation | 11.9 | 6.3 | 1.2 | 3.4 | 0.9 |
| Amortization | 11.5 | 12.6 | 4.4 | 1.6 | 0.5 |
| Adjusted EBITDA | $144.8 | $11.0 | $10.2 | $11.7 | $(29.5) |
| Divided by: |  |  |  |  |  |
| Total revenues | $719.3 | $155.8 | $65.8 | $88.1 | $— |
| Adjusted EBITDA margin | 20.1% | 7.1% | 15.5% | 13.3% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

*(in millions)*

|  | Three Months Ended March 31, 2020 CCM | CIT | CFT | CBF | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $107.7 | $16.4 | $2.8 | $(3.8) | $(20.4) |
| Non-operating (income) expense(1) | 0.3 | (0.8) | (3.3) | (0.3) | 12.4 |
| EBIT | 107.4 | 17.2 | 6.1 | (3.5) | (32.8) |
| Exit and disposal, and facility rationalization costs | 0.1 | 3.4 | — | 2.8 | — |
| Inventory step-up amortization and acquisition costs | 0.2 | — | 0.2 | — | 0.3 |
| Impairment charges | — | — | — | — | — |
| Losses (gains) from acquisitions and disposals | 0.3 | — | — | — | (0.1) |
| Losses (gains) from insurance | — | — | — | — | — |
| Losses (gains) from litigation | — | — | — | — | — |
| Losses on extinguishment of debt | — | — | — | — | 8.8 |
| Total non-comparable items | 0.6 | 3.4 | 0.2 | 2.8 | 9.0 |
| Adjusted EBIT | 108.0 | 20.6 | 6.3 | (0.7) | (23.8) |
| Depreciation | 12.2 | 6.0 | 1.3 | 4.4 | 0.7 |
| Amortization | 12.6 | 13.1 | 4.9 | 1.5 | 0.1 |
| Adjusted EBITDA | $132.8 | $39.7 | $12.5 | $5.2 | $(23.0) |
| Divided by: |  |  |  |  |  |
| Total revenues | $676.4 | $224.5 | $58.3 | $71.0 | $— |
| Adjusted EBITDA margin | 19.6% | 17.7% | 21.4% | 7.3% | NM |

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

### Outlook

Our expectations for segment and total revenues for 2021, compared to 2020 follow:

|  | 2021 Revenue | Primary Drivers |
| --- | --- | --- |
| Carlisle Construction Materials | Low-double digit growth | •Strong re-roofing demand •Price discipline •Strong architectural metals, European and polyurethanes markets |
| Carlisle Interconnect Technologies | Mid-to-high-single digit decline | •Commercial aerospace performance at or near bottom; backlog improving |
| Carlisle Fluid Technologies | Low-double digit growth | •Focus on new product introductions and price realization •Markets strengthening |
| Carlisle Brake & Friction | 30% growth | •Construction and agriculture markets strengthening •Bookings up over 80% in first quarter year-over-year |
| Total Carlisle | Low-double digit growth |  |

For the year 2021, we expect:

- Corporate expenses of approximately $120 million;
- Depreciation and amortization expense of approximately $225 million;
- Capital expenditures between $150 million and $175 million;
- Interest expense, net of interest income, of approximately $75 million; and
- Base tax rate of approximately 25%.

### Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of COVID-19 on our businesses, including on customer demand, supply chains and distribution systems, production, our ability to maintain appropriate labor levels, our ability to ship products to our customers, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the identification of strategic acquisition targets and our successful completion of any transaction and integration of our strategic acquisitions; the cyclical nature of our businesses; and the outcome of pending and future litigation and governmental proceedings; and the other factors discussed in the reports we file with or furnish to the Securities and Exchange Commission ("SEC") from time to time. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena may adversely affect general market conditions and our future performance. Any forward-looking statement speaks only as of the date on which that statement is made, and we undertake no duty to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date on which that statement is made, unless otherwise required by law. New factors emerge from time to time and it is not possible for management to predict all of those factors, nor can it assess the impact of each of those factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.

## Market risk

As filed, 272 characters.

There have been no material changes in the Company’s market risk for the three months ended March 31, 2021. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s 2020 Annual Report on Form 10-K.

## Controls and procedures

As filed, 861 characters.

a. Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of March 31, 2021, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b. Changes in internal controls. During the first three months of 2021, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 149 characters.

There have been no material changes in the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" in our 2020 Annual Report on Form 10-K.

Filed Apr 27, 2021.
Source: SEC EDGAR, the filing index for accession 0000790051-21-000116. Last ingested by Listed: Nov 10, 2026, 16:42 ET. No prices; not investment advice.
